Evidence map›Paper›PMID 34432393›Full record

ArticleDiagnostic cytopathology2021

Next-generation sequencing analyses using biopsy forceps and cytology brush rinse fluids for lung cancer genotyping: Report of five cases.

Yoshimasa Nakazato, Hiromi Machida, Yukimi Horii, Masato Onozaki, Kensuke Ohikata, Yuko Kaneko, Ryo Arai, Seiji Niho, Kazuyuki Ishida

Open access · hybridAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostic cytopathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yoshimasa NakazatoDepartment of Diagnostic Pathology, Dokkyo Medical University, Mibu, Japan.
Hiromi MachidaDepartment of Pathology, Dokkyo Medical University Hospital, Mibu, Japan.
Yukimi HoriiDepartment of Pathology, Dokkyo Medical University Hospital, Mibu, Japan.
Masato OnozakiDepartment of Diagnostic Pathology, Dokkyo Medical University, Mibu, Japan.
Kensuke OhikataDepartment of Diagnostic Pathology, Dokkyo Medical University, Mibu, Japan.
Yuko KanekoDepartment of Diagnostic Pathology, Dokkyo Medical University, Mibu, Japan.
Ryo AraiDepartment of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, Japan.
Seiji NihoDepartment of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Mibu, Japan.
Kazuyuki IshidaDepartment of Diagnostic Pathology, Dokkyo Medical University, Mibu, Japan.ORCID https://orcid.org/0000-0002-2804-4588
Dokkyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung NeoplasmsSurgical InstrumentsAgedAged, 80 and overBiopsyCytodiagnosisFemaleGenotypeGenotyping TechniquesHigh-Throughput Nucleotide SequencingHumansMale

Identifiers

PMID34432393
PMCPMC9291978
OpenAlexW3193573748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.